Stockscreener 앱 받기
1.42
2.16%
0.03
시간 외 거래:
1.41
-0.01
-0.70%
전일 마감가:
$1.39
열려 있는:
$1.4
하루 거래량:
68,703
Relative Volume:
0.31
시가총액:
$6.50M
수익:
$895.50K
순이익/손실:
$-26.30M
주가수익비율:
-0.0217
EPS:
-65.5728
순현금흐름:
$-23.84M
1주 성능:
-2.74%
1개월 성능:
-17.92%
6개월 성능:
-49.47%
1년 성능:
-85.00%
1일 변동 폭
$1.38
$1.47
1주일 범위
$1.38
$1.53
52주 변동 폭
$1.2801
$14.39
Mainz Biomed N V Stock (MYNZ) Company Profile
MYNZ을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MYNZ
Mainz Biomed N V
|
1.42 | 7.52M | 895.50K | -26.30M | -23.84M | -65.57 |
|
TMO
Thermo Fisher Scientific Inc
|
567.64 | 212.37B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
212.21 | 151.04B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
720.21 | 57.66B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
146.77 | 41.41B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
210.12 | 35.93B | 15.90B | 1.28B | 2.21B | 7.2842 |
Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-14 | 개시 | Maxim Group | Buy |
| 2024-11-25 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-11-21 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-21 | 개시 | H.C. Wainwright | Buy |
Mainz Biomed N V 주식(MYNZ)의 최신 뉴스
Can Mainz Biomed N.V. (4TO) stock sustain free cash flowLong Setup & AI Forecasted Entry/Exit Points - newser.com
What dividend safety score for Mainz Biomed N.V. stockJuly 2025 News Drivers & AI Based Buy and Sell Signals - fcp.pa.gov.br
What margin trends mean for Mainz Biomed N.V. stock2025 Breakouts & Breakdowns & Reliable Volume Spike Trade Alerts - newser.com
Building trade automation scripts for Mainz Biomed N.V.Weekly Investment Report & Long-Term Safe Return Strategies - newser.com
Is a relief rally coming for Mainz Biomed N.V. holdersPortfolio Risk Report & Weekly Consistent Profit Watchlists - newser.com
Why Mainz Biomed N.V. (4TO) stock attracts wealthy investorsChart Signals & High Win Rate Trade Tips - newser.com
Will Mainz Biomed N.V. outperform the marketProduct Launch & Reliable Entry Point Alerts - newser.com
Can Mainz Biomed N.V. stock deliver strong Q4 earningsWeekly Profit Recap & Stepwise Trade Signal Guides - newser.com
Is Mainz Biomed N.V. stock a safe investment in uncertain markets - newser.com
Is Mainz Biomed N.V. stock ready for a breakoutRecession Risk & Verified Entry Point Detection - newser.com
Will Mainz Biomed N.V. stock remain a Wall Street favoriteWeekly Trade Recap & High Accuracy Investment Entry Signals - newser.com
How Mainz Biomed N.V. (4TO) stock performs in easing cyclesQuarterly Portfolio Report & Daily Profit Focused Screening - newser.com
What’s the recovery path for long term holders of Mainz Biomed N.V.Earnings Overview Summary & Low Volatility Stock Suggestions - newser.com
Using portfolio simulators with Mainz Biomed N.V. includedPortfolio Value Summary & Risk Managed Investment Signals - newser.com
Is Mainz Biomed NV a good long term investmentWeekly Market Snapshot & Invest With Confidence - earlytimes.in
Will Mainz Biomed N.V. (4TO) stock return to pre crash levelsTrade Entry Summary & Weekly Breakout Stock Alerts - newser.com
How Mainz Biomed N.V. stock valuations compare to rivalsWeekly Trend Report & Verified Stock Trade Ideas - fcp.pa.gov.br
Will Mainz Biomed N.V. (4TO) stock rise with strong economy2025 Performance Recap & Real-Time Buy Signal Alerts - newser.com
Can Mainz Biomed N.V. stock continue upward trendEarnings Summary Report & Verified High Yield Trade Plans - newser.com
Key resistance and support levels for Mainz Biomed N.V.Market Activity Report & Technical Pattern Based Signals - newser.com
Will Mainz Biomed N.V. (4TO) stock benefit from mergersJuly 2025 Opening Moves & Technical Buy Zone Confirmations - newser.com
How forex fluctuations impact Mainz Biomed N.V. (4TO) stock2025 Earnings Impact & Free Technical Pattern Based Buy Signals - newser.com
What to do if you’re stuck in Mainz Biomed N.V.Portfolio Value Summary & Weekly Market Pulse Updates - newser.com
Mainz Biomed N V (MYNZ) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.13%
0.65%
자본화:
|
볼륨(24시간):